Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC SRI-37330 | 2322245-42-9 | 99.2% | 388.41 | C16H19F3N4O2S | 5 MG
Supplier: Medchemexpress LLC HY1421145MG
SRI-37330 is an orally bioavailable thioredoxin-interacting protein (TXNIP) inhibitor used in preclinical research. It has been shown to inhibit glucagon secretion and function, reduce hepatic glucose production, and reverse hepatic steatosis, making it useful for studies of type 2 diabetes and metabolic disease. The compound is supplied with analytical data and handling documentation for laboratory use.
- Orally bioavailable TXNIP inhibitor.
- Inhibits glucagon secretion and reduces hepatic glucose production.
- Reverses hepatic steatosis in preclinical models.
- High purity (99.16%) suitable for biochemical assays.
- Soluble in DMSO and compatible with standard in vivo formulations.
- Provided with SDS, COA, and handling instructions.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?